Following immunomagnetic sorting with CD133 beads, CD133+ tumor cells were cultured in serum-free DMEM-F12 medium supplemented with 20 ng/ml EGF and 10 ng/ml bFGF, and analyzed using flow cytometry (EPICS XL flow cytometer; Beckman Coulter). This evidence concerns the gene FGF2 and neoplasm.